HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (2- chloro- 4- ((6,7- dimethoxy- 4- quinazolinyl)oxy)phenyl)- N'- propylurea

a VEGF receptor-2 tyrosine kinase inhibitor; structure in first source
Also Known As:
KRN 633; KRN-633; KRN633
Networked: 6 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nakahara, Tsutomu: 2 articles (02/2013 - 01/2010)
2. Nagamitsu, Tohru: 2 articles (02/2013 - 01/2010)
3. Ishii, Kunio: 2 articles (02/2013 - 01/2010)
4. Ozaki, Hiromi: 2 articles (02/2013 - 01/2010)
5. Abe, Naomichi: 2 articles (02/2013 - 01/2010)
6. Wada, Yoshiko: 2 articles (02/2013 - 01/2010)
7. Nakamura, Kazuhide: 2 articles (01/2006 - 12/2004)
8. Takahashi, Kazumi: 2 articles (01/2006 - 12/2004)
9. Yamamoto, Atsushi: 2 articles (01/2006 - 12/2004)
10. Taguchi, Eri: 2 articles (01/2006 - 12/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Pathologic Neovascularization
3. Weight Loss (Weight Reduction)
4. Premature Birth (Birth, Premature)
5. Mesothelioma

Related Drugs and Biologics

1. Protein-Tyrosine Kinases (Tyrosine Kinase)
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
4. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
5. Protein Kinase C
6. enzastaurin
7. SU 5416 (SU5416)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Withholding Treatment